Even in generosity, it seems, nursing homes can’t catch a break. The headlines imply as much.
Experts propose new Medicare payment model that emphasizes collaboration between nursing homes, hospitals
By
Danielle Brown
Nov 19, 2021
Post-acute care facilities could benefit from a new, comprehensive care payment model that would reimburse providers through collaborations with hospitals that aim to improve care and outcomes for residents,...
Sorry, that’s not the full recipe for fixing nursing homes
By
John O'Connor
Jun 04, 2012
The Atlantic’s recent article called ‘How to Fix Nursing Homes’ is a well-written and thoughtful piece. My only gripe is that the headline is a bit of a reach.
SNF Medicare margins: What MedPAC doesn’t know
By
Betsy Rust
Apr 29, 2016
The articulation of data is vitally important, and MedPAC is not the only entity interpreting, or misinterpreting, cost report and claim data.
Regulators go overtime fielding comments and questions on nursing home star-rating system
Jun 25, 2008
While the focus of regulators’ “Open Door Forum” conference call Tuesday might have first appeared to be about getting ready for the December rollout of a new nursing home ranking system,...
Physical therapy group opposes proposed 3.6% reimbursement cut
By
Kristen Fischer
Sep 14, 2023
The Alliance for Physical Therapy Quality and Innovation (APTQI) called on the Centers for Medicare & Medicaid Services to revisit its Medicare doctor fee proposal for next year, saying the changes could...
Healthcare to remain dominant issue in 2019
By
Brendan Williams
Dec 14, 2018
There is a way Democrats could capitalize upon the enthusiasm of many in their base for “Medicare for All.” They could join together with Republicans and make Medicare responsible for what so many...
The heart of what we believe
By
Elizabeth Newman
Sep 25, 2012
If the AARP convention last week was any indication, some seniors aren’t buying what Paul Ryan is selling. The question is, are you?
CLASS Act math
By
Liza Berger
Dec 01, 2009
If you are confused about the financial implications of the highly publicized CLASS Act, you are not alone. If it’s supposed to be solvent and actuarially sound over the long term, why is the program...
To save itself, might Medicare deny coverage of controversial new Alzheimer’s drug?
By
Kimberly Marselas
Jun 28, 2021
The true price to administer aducanumab — a controversial new Alzheimer’s treatment — may actually be closer to $100,000 annually than other, lower estimates and is just one reason the Centers for...